Oral Cancer Therapy Market Size (2024 - 2029)

Oral Cancer Therapy Market Analysis

The Oral Cancer Therapy Market size is estimated at USD 2.05 billion in 2024, and is expected to reach USD 2.65 billion by 2028, growing at a CAGR of 5.32% during the forecast period (2024-2028).

COVID-19 undoubtedly had a huge impact on the oral cancer market. The repercussions of the pandemic were mainly related to travel restrictions and the conversion of hospitals to COVID-19 centers, fear in the minds of the public, shortage of human resources, etc. To mitigate the reduction in the number of cases, many cancer hospitals have started services like telecommunication and telemedicine. For instance, according to the article published by the Asian Journal of Oral Health and Allied Sciences in January 2022, many telemedicine applications were launched during the pandemic for teleconsultation, such as Practo, Mfine, and TATA Health provide teleconsultation. Hence, these services have increased teleconsultation, which has shown a lucrative impact on market growth during the pandemic. Currently, COVID-19 has subsided, and services have their traction again in every country and this opportunity would be exploited to shape the oral cancer market.

Rising tobacco use and smoking habits, an increase in oral cancer patients with unmet needs, and a need for early treatment are driving the oral cancer market during the forecast period. The emergence and increasing usage of newer tobacco and nicotine products make tobacco use one of the major public health problems globally.

Tobacco use increases the risk of oral cancer and other oral-related diseases. For instance, a series of authoritative reports issued by the United States government and other various international health agencies have conclusively established that tobacco use, especially cigarette smoking, increases the burden of oral cancer patients. According to the American Lung Association, in May 2023, a burning cigarette produces more than 7000 chemicals, of which 69 are carcinogens. Hence, these carcinogens lead to oral cancer, and continued cigarette smoking is expected to have a significant impact on the market over the study period.

Furthermore, the new research studies on various treatments for oral cancers are expected to have a significant impact on the market growth. For instance, in May 2023, Janssen Pharmaceutical performed an open-label phase 2 study to assess the safety and effectiveness of enzalutamide in combination with a gonadotropin-releasing hormone agonist in subjects with salivary gland carcinoma that expresses the androgen receptor and is locally advanced metastatic. Similarly, in September 2023, researchers at New York University developed ORAI1 fuels for oral cancers that may provide promising therapeutic. Targeting this protein could provide a new approach to treating oral cancer, which causes persistent pain that worsens as it progresses. Hence, such developments increase the availability of new drugs in the market over the coming years, thereby projecting market growth over the forecast period.

However, a lack of awareness and the adverse effects of treatments for oral cancer impede the growth of the oral cancer market over the forecast period.

Oral Cancer Therapy Industry Segmentation

As per the scope of the report, oral cancer is a broad term for cancer that affects the mouth. There are various types of oral cancer, like lymphoma, mucosal melanoma, sarcomas, and others. The oral cancer market is segmented by therapy type (chemotherapy, targeted drug therapy, immunotherapy, radiation therapy, and other types), end-users (hospitals, cancer centers, research organizations, and other end-users), administration type (oral, injectable, and other administration types), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.

The report offers the value (in USD) for the above segments.